Philippe Boucheron
MBA
Board
Advicenne
France
Biography
Philippe Boucheron has an engineering degree in Biochemical Engineering and Microbial Genetics from the National Institute for Applied Sciences in Toulouse, an MSc in Biochemical Engineering from Polytechnique Montreal and an MBA from INSEAD (European Institute for Business Administration). From 1993 to 1996 Philippe Boucheron was a member of staff at BioCapital LP, one the largest Canadian risk capital funds devoted to biotechnology. From 1997 to 2000 he managed an average value shares research team at ING Barings Ferri in Paris, where he devoted a large part of his time to monitoring French and European biotechnology and health values. In 2000 he co-founded Bioam and became a member of the Board of Directors; in 2004 he was appointed Chairman of the Board. He has a seat on the councils of Aureus Pharma, Libragen, Ademtech, Integragen, Cryolog, SSI and TxCell. Following the merger of Bioam with CDC Entreprises in July 2010 Philippe Boucheron has joined the CDC Entreprises team for direct investment in life sciences (Innobio and Bioam funds).
Research Interest
Business Development
